| (Values in U.S. Thousands) | Dec, 2022 | Sep, 2022 | Jun, 2022 | Mar, 2022 | Dec, 2021 |
| Sales | 413,930 | 410,790 | 302,410 | 410,590 | 487,480 |
| Sales Growth | +0.76% | +35.84% | -26.35% | -15.77% | +18.25% |
| Net Income | 12,930 | 14,350 | 14,160 | 35,020 | 64,980 |
| Net Income Growth | -9.90% | +1.34% | -59.57% | -46.11% | +71.90% |
Cowen Group Inc (COWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
COWEN GROUP, INC., through its operating subsidiaries, provides investment banking, equity research, sales and trading, asset management and alternative asset management services to companies and institutional investor clients in the healthcare, technology, telecommunications, aerospace and defense, consumer and alternative energy sectors. Cowen's asset management business includes teams based in the U.S. and the U.K. Cowen's U.S. team focuses on a growth-oriented investment style centered on small and mid-sized companies based primarily in North America. Cowen's U.K. team provides traditional asset management products, focusing on a global equity strategy. Cowen's alternative asset management business consists of Cowen Healthcare Royalty Partners, which invests principally in commercial-stage biopharmaceutical products and companies, and Cowen Capital Partners, which manages a portfolio of middle market private equity investments for third party investors.
Fiscal Year End Date: 12/31